ENTA

ENANTA PHARMACEUTICALS INC

ENTA·29251M106·US·Common Stock·Healthcare - Biotechnology-13D/G

ENTA (ENANTA PHARMACEUTICALS INC) is held by 78 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($47.7M), BlackRock, Inc. ($39.2M), FARALLON CAPITAL MANAGEMENT, L.L.C. ($36.3M). Net institutional sentiment: Mixed.

78
Holders
Avg rating(19 Elite)
$241.5M
Total Value
59% (87)
Fund Consensus
46 buying - 32 selling
ENTASmart Money Verdict
View all
Held by 78 funds
19 elite
Who's Trading
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
ActivistDTDeep Track Capital, LP6.8%Feb 13, 2026
ActivistFAFarallon Capital Partners, L.P.1.8%Feb 5, 2026
ActivistICIntegrated Core Strategies (US) LLC2.3%Jan 20, 2026
InsiderLRLuly Jay R.Sell $67KDec 5, 2025
InsiderOSOr Yat SunSell $34KDec 5, 2025
InsiderTITrout Harry R. IIISell $8KDec 5, 2025
InsiderCSCapps Kathleen S.Sell $5KDec 5, 2025
ActivistJANUS HENDERSON GROUP PLCJANUS HENDERSON GROUP PLC12.1%Nov 7, 2025
ActivistBlackRock, Inc.BlackRock, Inc.7.8%Apr 17, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.8M(+1.5%)$47.7M0.0%-5.14%
30
Increased
3.1M(+0.9%)$39.2M0.0%+37.63%
29
Increased
2.9M(+3.6%)$36.3M0.2%-67.43%
36
New
1.2M$14.9M0.0%-6.93%
39
New
948,904$12M0.0%-6.93%
39
Increased
882,097(+31.6%)$11.1M0.0%+13.85%
35
Increased
725,061(+12.3%)$9.2M0.0%-65.74%
31
Increased
665,258(+3.6%)$8.4M0.0%-61.93%
29
Increased
562,106(+7.3%)$7.1M0.0%+33.03%
29
Increased
313,157(+33.4%)$4M0.0%+54.22%
34
Decreased
309,511(-8.9%)$3.9M0.0%+6.30%
0
Increased
294,971(+34.9%)$3.7M0.0%-63.59%
34
Decreased
267,364(-6.3%)$3.4M0.0%-6.91%
0
Increased
265,088(+21.1%)$3.3M0.0%+22.90%
32
Increased
262,533(+181.8%)$3.3M0.0%-9.50%
43
Increased
240,968(+4.8%)$3M0.0%-72.09%
28
Decreased
210,070(-45.5%)$2.7M0.0%-15.74%
0
Decreased
203,252(-4.0%)$2.6M0.0%-34.08%
0
Decreased
182,002(-28.3%)$2.3M0.0%-21.04%
0
New
175,856$2.2M0.0%-6.93%
36

Showing 1-20 of 87

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used